• Login
    Search 
    •   ResearchSpace Home
    • Caprisa (Centre for the Aids programme of research in South Africa)
    • Search
    •   ResearchSpace Home
    • Caprisa (Centre for the Aids programme of research in South Africa)
    • Search
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-10 of 23

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    The abandoned trials of pre-exposure prophylaxis for HIV : what went wrong? 

    Singh, Jerome Amir.; Mills, Edward J. (Plos., 2005)
    Discusses the impact of irresponsible reporting and activism against the use of the oral antiretroviral drug tenofovir as a pre-exposure prophylaxis (PREP) for HIV/AIDS. Protests against trials of PREP; Concerns of the ...
    Thumbnail

    Antiretroviral prophylaxis for HIV prevention reaches a key milestone. 

    Abdool Karim, Salim Safurdeen.; Abdool Karim, Quarraisha. (Elsevier., 2012)
    No abstract available.
    Thumbnail

    Balancing efficiency, equity and feasibility of HIV treatment in South Africa – development of programmatic guidance. 

    Baltussen, Rob.; Mikkelsen, Evelinn.; Tromp, Noor.; Hurtig, AnneKarin.; Byskov, Jens.; Olsen, Oystein.; Baeroe, Kristine.; Hontelez, Jan A.; Singh, Jerome Amir.; Norheim, Ole F. (BioMed Central., 2013)
    South Africa, the country with the largest HIV epidemic worldwide, has been scaling up treatment since 2003 and is rapidly expanding its eligibility criteria. The HIV treatment programme has achieved significant results, ...
    Thumbnail

    Patients’ readiness to start highly active antiretroviral treatment for HIV. 

    Gebrekristos, Hirut T.; Mlisana, Koleka Patience.; Abdool Karim, Quarraisha. (BMJ publishing group., 2005)
    Assessing whether patients are ready to start antiretroviral treatment may improve HIV prevention and treatment outcomes.
    Thumbnail

    An adaptive design to bridge the gap between phase 2b/3 microbicide effectiveness trials and evidence required for licensure. 

    Taylor, Douglas.; Grobler, Anna Christina.; Abdool Karim, Salim Safurdeen. (Sage., 2012)
    Background. Vaginally and rectally applied microbicides are being developed to help prevent sexual acquisition of HIV. Due to the lack of surrogate outcomes, the path toward licensure typically moves directly from expanded ...
    Thumbnail

    Innate immune activation enhances HIV acquisition in women, diminishing the effectiveness of tenofovir microbicide gel. 

    Naranbhai, Vivek.; Abdool Karim, Salim Safurdeen.; Altfeld, Marcus.; Samsunder, Natasha.; Durgiah, Raveshni.; Sibeko, Sengeziwe.; Abdool Karim, Quarraisha.; Carr, William Henry. (Oxford University Press., 2011)
    The antiretroviral agent, tenofovir, formulated as a vaginal microbicide gel, reduces human immunodeficiency virus (HIV) acquisition by 39% in women. This study assessed the role of preexisting immune activation in ...
    Thumbnail

    Topical microbicides - What's new? 

    Abdool Karim, Quarraisha.; Baxter, Cheryl.; Abdool Karim, Salim Safurdeen. (Lippincott Williams & Wilkins., 2013)
    Topical microbicides are an important, promising but complex HIV prevention technology under development. After 11 disappointing effectiveness trial outcomes of 6 candidate products (some tested as multiple doses and ...
    Thumbnail

    An AIDS-Free Generation? 

    Abdool Karim, Salim Safurdeen. (American Association for the Advancement of Science., 2012)
    No abstract available.
    Thumbnail

    HIV pre-exposure prophylaxis in injecting drug users. 

    Abdool Karim, Salim Safurdeen. (Elsevier., 2013)
    No abstract available.
    Thumbnail

    ARV-based HIV prevention for women Á where are we in 2014. 

    Mastro, Timothy D.; Sista, Nirupama.; Abdool Karim, Quarraisha. (International AIDS Society., 2014)
    Abstract available in pdf.
    • 1
    • 2
    • 3

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
    Theme by 
    @mire NV
     

     

    Browse

    All of ResearchSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsAdvisorsTypeThis CommunityBy Issue DateAuthorsTitlesSubjectsAdvisorsType

    My Account

    LoginRegister

    Discover

    AuthorAbdool Karim, Salim Safurdeen. (15)Abdool Karim, Quarraisha. (12)Grobler, Anna Christina. (5)Baxter, Cheryl. (4)Mlisana, Koleka Patience. (4)Kharsany, Ayesha Bibi Mahomed. (3)Naidoo, Kogieleum. (3)Sibeko, Sengeziwe. (3)Taylor, Douglas. (3)Altfeld, Marcus. (2)... View MoreSubject
    Antiretroviral agents. (23)
    HIV infections--Prevention. (6)AIDS (Disease) in women--Prevention. (4)HIV infections--Drug therapy. (4)Tenofovir gel. (4)AIDS vaccines. (3)Antiretroviral microbicides. (3)Microbicides. (3)AIDS (Disease) in women--Treatment. (2)AIDS (Disease)--Treatment. (2)... View MoreDate Issued2010 - 2017 (18)2003 - 2009 (5)Has File(s)true (23)

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
    Theme by 
    @mire NV